| Product Code: ETC10081569 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Pharmacogenetic Testing Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Vietnam Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Vietnam Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Vietnam Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Vietnam Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Vietnam Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Vietnam Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Vietnam Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Vietnam Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Vietnam Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and adoption of personalized medicine in Vietnam |
4.2.2 Government initiatives to promote precision medicine and healthcare advancements |
4.2.3 Growing prevalence of chronic diseases and genetic disorders in the Vietnamese population |
4.3 Market Restraints |
4.3.1 Limited infrastructure for genetic testing and personalized medicine services in Vietnam |
4.3.2 High cost associated with pharmacogenetic testing and personalized medicine |
4.3.3 Lack of skilled healthcare professionals trained in pharmacogenetics |
5 Vietnam Pharmacogenetic Testing Market Trends |
6 Vietnam Pharmacogenetic Testing Market, By Types |
6.1 Vietnam Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Vietnam Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Vietnam Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Vietnam Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Vietnam Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Vietnam Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Vietnam Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Vietnam Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Vietnam Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Vietnam Pharmacogenetic Testing Market Export to Major Countries |
7.2 Vietnam Pharmacogenetic Testing Market Imports from Major Countries |
8 Vietnam Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Number of healthcare facilities offering pharmacogenetic testing services in Vietnam |
8.2 Percentage of healthcare professionals in Vietnam trained in pharmacogenetics |
8.3 Patient engagement and satisfaction levels with personalized medicine services in Vietnam |
9 Vietnam Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Vietnam Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Vietnam Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Vietnam Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Vietnam Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Vietnam Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Vietnam Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Vietnam Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Vietnam Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Vietnam Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here